Roxro Announces FDA Approval of Sprix
Links shared publicly online about this topic.
- 1,161total visits
Roxro Announces FDA Approval of Sprix
View full resource at drugs.com
Tags: Pain, FDA, NSAIDs, Toradol
Most Recently Shared on May 17, 2010 at 11:32 pm By:
ROXRO Announces FDA Approval Of SPRIX(TM)
medicalnewstoday.com — “ROXRO PHARMA, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved SPRIX™ (ketorolac tromethamine) Nasal Spray, for the short-term (up to 5 days) management of acute” View full resource at medicalnewstoday.com
Most Recently Shared on May 25, 2010 at 2:10 pm By:
ROXRO Announces FDA Approval Of SPRIX(TM) http://mnt.to/3D3b #pharma #pharmaceutical
ROXRO Announces FDA Approval of SPRIX - FiercePharma
fiercepharma.com — “ROXRO Announces FDA Approval of SPRIX (Ketorolac Tromethamine) - First Non-narcotic Intranasal Analgesic for Moderate to Moderately Severe Pain - Download image MENLO PARK, Calif., May 17... Read more...” View full resource at fiercepharma.com
Most Recently Shared on May 17, 2010 at 6:38 pm By:
FDA approves ROXRO PHARMA's SPRIX Nasal Spray
news-medical.net — “ROXRO PHARMA, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved SPRIX" (ketorolac tromethamine) Nasal Spray, for the short-term (up to 5 days) management of acute moderate to moderately severe pain that requires analgesia at the opioid level.” View full resource at news-medical.net
Most Recently Shared on May 17, 2010 at 5:47 pm By:
Stroke News: FDA approves ROXRO PHARMA's SPRIX Nasal Spray: ROXRO PHARMA, Inc. announced today that the U.S. Foo... http://twurl.nl/jp5kc1
Sprix approved for acute moderate to moderately severe pain - MPR
empr.com — “The FDA has approved Sprix (ketorolac tromethamine nasal spray, from Roxro Pharma) for the short-term (up to 5 days) management of acute moderate to moderately severe pain that requires analgesia at the opioid level.” View full resource at empr.com
Most Recently Shared on May 17, 2010 at 4:55 pm By:
MPR News: Sprix approved for acute moderate to moderately severe pain: The FDA has approved Sprix (ketorolac trome... http://bit.ly/beALNP
Advertisement

